Pharmaceutical Technology

Join us as we explore a lively discussion focused on cell and gene therapy topics in a recent Buy, Sell, Hold panel featured on BioPharm International. In part 1, Cellares co-founder and CEO, Fabian Gerlinghaus, joins a notable group of experts, including Dr. Claudia Zylberberg, Board Chair and Co-Founder of Arscience Biotherapeutics & Board Chair and Co-Founder of Akron Biosciences, and Benjamin McLeod, Director, Cell & Gene Therapy Segment, NanoMosaic, to discuss critical topics ranging from the importance of focusing on orphan diseases to the impact AI and quantum computing will have on innovation. Don't miss out on this valuable exchange of knowledge and innovation. View the full panel discussion here: https://lnkd.in/e5kRVRwV

Explore key properties for optimizing biologic dry powder formulations with Mireia Puig and Josh Newman in the live virtual event sponsored by Vectura Group. Register now: https://ow.ly/X7Po50TYqNr

The product license holder must have a supplier oversight system in place, says Siegfried Schmitt, PhD, vice president, Technical, Parexel. https://lnkd.in/eS8UaZ7r

Specialty matrix drug delivery systems are key to patient-centric drug design. In this live virtual event from IFF, a panel of experts explore how a unique excipient provides critical material properties that result in robust drug product performance. Register now: https://ow.ly/8fjQ50TXEmv

Abzena will be expanding its quality control testing capabilities at its San Diego, Calif. biologics development and manufacturing site. https://lnkd.in/exjj-UKp

Check out our featured virtual events, including live webcasts, panel discussions, and on-demand webinars from Pharmaceutical Technology®! #SolidDosage #Formulation #Biologics

Abzena will be expanding its quality control testing capabilities at its San Diego, Calif. biologics development and manufacturing site. https://lnkd.in/exjj-UKp

Control Strategies and Method Development for Nitrosamines in APIs and Drug Products Learn how to navigate the regulatory landscape utilizing current method development technologies for impurity control in late-phase API manufacturing. Register now: https://lnkd.in/eUK_8Uvr

Live Virtual Event: Solving the Insoluble: Webinar on the Science and Application of the Dispersome® Technology Join Korbinian Löbmann, PhD and Emmanuel Heinrich, PhD to learn how the technology can be applied for developing more new drugs into commercial products and allows for improvement of existing drugs. Register now: https://lnkd.in/gSixXCpp

Abzena will be expanding its quality control testing capabilities at its San Diego, Calif. biologics development and manufacturing site. https://lnkd.in/exjj-UKp